International Journal of Epidemiology · 2018 · 19 citations · 40 references
MedicineHealth BehaviorPreventive MedicineCancer EpidemiologyCancer PreventionEpidemiologyCancer Burden AssessmentCancer MortalityCancer RegistriesDisease ControlLung CancerRisk ReductionCancer Incidence BurdenCancer Mortality BurdenDisease Burden AnalysisLung Cancer EpidemiologyLung Cancer MortalityPreventable BurdenRisk Factor DistributionSmoking Attributable Cancer Burden
Background: Knowledge of preventable disease and differences in disease burden can inform public health action to improve health and health equity. We quantified the future lung cancer burden preventable by behavioural modifications across Australia. Methods: We pooled seven Australian cohort studies (n = 367 058) and linked them to national registries to identify lung cancers and deaths. We estimated population attributable fractions and their 95% confidence intervals (CIs) for modifiable risk factors, using risk estimates from the cohort data and risk factor exposure distribution from contemporary national health surveys. Results: During the first 10-year follow-up, there were 2025 incident lung cancers and 20 349 deaths. Stopping current smoking could prevent 53.7% (95% CI, 50.0-57.2%) of lung cancers over 40 years and 18.3% (11.0-25.1%) in 10 years. The smoking-attributable burden is highest in males, those who smoke <20 cigarettes per day, are <75 years of age, unmarried, of lower educational attainment, live in remote areas or are healthy weight. Increasing physical activity and fruit consumption, if causal, could prevent 15.6% (6.9-23.4%) and 7.5% (1.3-13.3%) of the lung cancer burden, respectively. Jointly, the three behaviour modifications could prevent up to 63.0% (58.0-67.5%) of lung cancers in 40 years, and 31.2% (20.9-40.1%) or 43 300 cancers in 10 years. The preventable burden is highest among those with multiple risk factors. Conclusions: Smoking remains responsible for the highest burden of lung cancer in Australia. The uneven burden distribution distinguishes subgroups that could benefit the most from activities to control the world's deadliest cancer.
40
Meta-analysis in clinical trials
Rebecca DerSimonian, Nan M. Laird · Controlled Clinical Trials · 1986 · 39.3K citations
Mohammad H. Forouzanfar, Ashkan Afshin, Lily Alexander et al. · The Lancet · 2016 · 7.8K citations · Full text
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
Michael Marmot, Tola Atinmo, T. Byers et al. · Choice Reviews Online · 2008 · 5.4K citations · Full text
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Béatrice Secretan, Chiara Scoccianti, Dana Loomis et al. · New England Journal of Medicine · 2016 · 3.5K citations · Full text
Medicine, Cancer Biology, Oncology +14
Mohammad H. Forouzanfar, Lily Alexander, H Ross Anderson et al. · The Lancet · 2015 · 2.7K citations · Full text
Public Health, Health Sciences, Population Health Sciences +17